Markers of bacterial translocation in end-stage liver disease - Wikidata - awgldk - TriplyDB

Markers of bacterial translocation in end-stage liver disease

Markers of bacterial translocation in end-stage liver disease

http://www.wikidata.org/entity/Q26783888

about

Alteration of the serum microbiome composition in cirrhotic patients with ascites.Rifaximin and Propranolol Combination Therapy Is More Effective than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study.Bacterial translocation in critical illness.The proportion of different interleukin-17-producing T-cell subsets is associated with liver fibrosis in chronic hepatitis C.Probiotic Mixture Golden Bifido Prevents Neonatal Escherichia coli K1 Translocation via Enhancing Intestinal Defense Increased serum C-reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosis.Rifaximin Reduces Markers of Inflammation and Bacterial 16S rRNA in Zambian Adults with Hepatosplenic Schistosomiasis: A Randomized Control Trial.Rifaximin has the potential to prevent complications of cirrhosis

P2860

Q36835625-401DA113-3466-478B-B056-3D1F794EB396 Q38708565-51D1023E-F575-4032-A55C-4A7B3BA80A7A Q39130029-A8479AA5-0A55-48DF-8301-6D1B0B3C4EEA Q40351950-DE8E4B2C-8D99-4099-B373-D7BA342BAD59 Q42363225-8E17D244-418A-473B-8560-D92928F8B4A5 Q47688442-62D74FF2-5F5B-4689-B6A7-E74FD8ED1059 Q50048814-176C5B8D-722C-44F2-A4B3-AA7DD8ECDB06 Q57067778-5CA2CD4D-519D-425C-A7C1-432D56A3DC3D

P2860

Markers of bacterial translocation in end-stage liver disease

http://www.wikidata.org/entity/Q26783888

description

2015 nî lūn-bûn

@nan

2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Markers of bacterial translocation in end-stage liver disease

@ast

Markers of bacterial translocation in end-stage liver disease

@en

Markers of bacterial translocation in end-stage liver disease

@nl

type

label

Markers of bacterial translocation in end-stage liver disease

@ast

Markers of bacterial translocation in end-stage liver disease

@en

Markers of bacterial translocation in end-stage liver disease

@nl

prefLabel

Markers of bacterial translocation in end-stage liver disease

@ast

Markers of bacterial translocation in end-stage liver disease

@en

Markers of bacterial translocation in end-stage liver disease

@nl

P1433

Q26783888-4C22F9CB-3736-46B9-AB77-D0F5FF858196

P1476

Q26783888-F99FAAD7-C4CC-4AF7-8D96-5BC4F7FD34B7

P2093

Q26783888-15CAD59F-192C-4689-9C02-05A161F1D4B2

Q26783888-65A0E2A7-0FCC-4EAC-B8E6-456CF302CA30

Q26783888-6D231F21-B4EF-4663-820C-CD03D8FC78C6

Q26783888-8C0488F1-DBE7-437D-9E9D-538941C04958

P2860

Q26783888-00DDCC36-173D-4756-A23B-61E6218E1CE3

Q26783888-01C767DB-209D-4C06-BDFA-EE69EC95F144

Q26783888-0CC8F1B5-F2B7-41A7-8ED6-BD85B405D549

Q26783888-150A8317-3172-4B5E-86F0-58E795EE32B1

Q26783888-1A7D5244-9E57-465F-AA4F-A88326DF362E

Q26783888-1D16F9C8-1666-4CC7-B2DF-CAEF0EE95B02

Q26783888-20FDD8EC-8591-4C0E-A72B-6589DC904DA8

Q26783888-27CF152A-9068-4E5E-8736-AA7D0D2211EA

Q26783888-2E10C93A-C266-4647-AF12-6BA73FE47279

Q26783888-2F9604F8-4A73-45D1-822F-0C7451EB2243

P304

Q26783888-0C9CFCBD-D6FF-418A-96D9-3E10DE4498CA

P31

Q26783888-3DF1FFE9-9A34-4DCE-83C6-B8DBDF8F1577

P3181

Q26783888-AFF0C25C-86F6-4D75-B512-8BC1AD5E2FF2

P356

Q26783888-AB23962A-9B94-46DF-80B5-8D83A19EC923

P407

Q26783888-1A1CB440-FD72-4611-9EBA-B4D40F2E2171

P433

Q26783888-282125A5-3628-40FA-B808-3694270FEBA7

P478

Q26783888-87C1693F-1209-437C-8488-34FA827CEF9C

P577

Q26783888-568DDA44-C23F-4C81-8FB3-FDA6762F8C46

P698

Q26783888-9C2759B2-1A39-4543-8293-DA3A23211950

P932

Q26783888-558E977D-78A8-400C-8052-EB5FF49B387E

P3181

P356

WJH.V7.I20.2264

P1433

World journal of hepatology

P1476

Markers of bacterial translocation in end-stage liver disease

@en

P2093

Garyfallia Kaltsa

http://www.w3.org/2001/XMLSchema#string

Giorgos Bamias

http://www.w3.org/2001/XMLSchema#string

Ioannis Koutsounas

http://www.w3.org/2001/XMLSchema#string

Spyros I Siakavellas

http://www.w3.org/2001/XMLSchema#string

P2860

Small intestinal bacterial overgrowth: diagnosis and treatment.

Bacterial regulation of intestinal immune responses.

Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model

Infection, coagulation, and variceal bleeding in cirrhosis.

Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease.

Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic dur

Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis.

Initial responses to endotoxins and Gram-negative bacteria.

Soluble CD14 levels reflect liver inflammation in patients with nonalcoholic steatohepatitis.

Human immunodeficiency virus-related microbial translocation and progression of hepatitis C.

P304

2264-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2093231

http://www.w3.org/2001/XMLSchema#string

P356

10.4254/WJH.V7.I20.2264

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26380651

http://www.w3.org/2001/XMLSchema#string

P932

4568487

http://www.w3.org/2001/XMLSchema#string